Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme

por Falkai, P., Reuteman-Fowler, C., Blahova, Z., Ikezawa, S., Marder, S. R., Krystal, J. H.
Publicado 2023